Makers Laboratories Ltd.

BSE: MAKERSL506919ISIN INE987A01010

Healthcare
Pharmaceuticals

Share price

₹215.10+14.05 (+6.99%)

as of 4 Nov 2026

Prices adjusted for splits and bonuses; cash dividends excluded. Volume shows actual shares traded.

52W high: ₹239.00
52W low: ₹109.00
Off 52W high: -10.00%
1M return: +19.27%
3M return: +31.76%
6M return: +42.03%
1Y return: +72.84%
20D avg volume: 1,192
50 DMA: ₹191.68
200 DMA: ₹158.69

Key ratios Consolidated

Market cap: ₹126.92 Cr
Current price: ₹215.10
52W high / low: ₹239.00 / ₹109.00
Face value: ₹10.00
P/E: 6.70
P/B: 1.62
EPS (TTM): ₹32.12
Book value / share: ₹132.79
ROE: —
ROCE: 9.00%
Operating margin: —
Net margin: —
Debt / equity: 0.04
Net debt: ₹4.56 Cr
Interest cover: 15.48
Dividend yield: —
Dividend / share (TTM): —
Payout: —
Cash conversion cycle: 117.2 days

Financials

Metric	Q2 FY27	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24
Income statement
	48.21	42.77	35.75	35.67	34.17	35.00	33.90	27.69	29.57	29.59	—
	0.75	0.61	0.76	0.33	0.36	0.27	0.12	0.88	10.51	0.38	—
	48.96	43.38	36.51	35.99	34.53	35.27	34.02	28.56	40.08	29.97	—
	37.41	37.09	31.78	32.85	33.24	33.29	31.90	27.88	29.10	29.55	—
	14.58	15.02	10.98	15.29	10.10	8.16	13.08	12.35	10.80	6.15	—
	5.10	5.47	5.72	4.01	5.45	7.03	3.75	3.58	3.41	3.87	—
	4.00	4.08	3.91	3.82	4.07	3.79	3.60	3.18	3.65	3.63	—
	0.15	0.15	0.17	0.20	0.22	0.18	0.18	0.19	0.43	0.49	—
	1.16	1.13	1.13	1.14	1.13	1.12	0.90	1.31	1.29	1.28	—
	11.47	11.43	11.73	11.85	11.91	9.21	13.25	9.89	11.44	9.67	—
	11.55	6.29	4.73	3.15	1.29	1.98	2.12	0.68	10.97	0.42	—
	0.00	0.00	0.00	0.00	0.00	0.00	-0.02	0.00	0.12	-0.89	—
	11.55	6.29	4.73	3.15	1.29	1.98	2.11	0.68	11.09	-0.47	—
	3.02	1.70	1.17	0.88	0.55	0.69	0.53	0.41	1.33	0.23	—
	8.53	4.60	3.56	2.27	0.75	1.29	1.58	0.27	9.76	-0.70	—
	6.69	2.55	1.85	1.59	-0.20	0.74	-0.08	-0.50	14.94	-1.67	—
Key metrics
	12.86	7.57	6.03	4.49	2.64	3.28	3.19	2.18	12.81	1.30	—
	26.70%	17.70%	16.90%	12.60%	7.70%	9.40%	9.40%	7.90%	43.30%	4.40%	—
	17.70%	10.80%	10.00%	6.40%	2.20%	3.70%	4.70%	1.00%	33.00%	-2.40%	—
	8.10%	—	3.70%	—	1.20%	—	1.80%	—	—	—	—
	41.10%	22.20%	5.50%	28.80%	15.60%	18.30%	—	—	—	—	—
	1,037.30%	256.60%	125.30%	740.70%	-92.30%	284.30%	—	—	—	—	—

Metric	TTM	FY26	FY25	FY24
Income statement
	162.40	140.59	120.75	—
	2.45	1.71	11.89	—
	164.84	142.30	132.64	—
	139.13	131.16	118.44	—
	55.87	44.54	42.38	—
	20.30	22.20	14.60	—
	15.81	15.59	14.05	—
	0.67	0.77	1.28	—
	4.56	4.53	4.79	—
	46.48	44.70	44.25	—
	25.72	11.15	14.20	—
	0.00	0.00	-0.79	—
	25.72	11.15	13.41	—
	6.77	3.29	2.50	—
	18.96	7.86	10.91	—
	12.68	3.99	12.70	—
Key metrics
	30.95	16.45	19.48	—
	19.06%	11.70%	16.10%	—
	11.67%	5.60%	9.00%	—
	—	9.00%	11.60%	—
	24.20%	16.40%	—	—
	387.40%	-28.00%	—	—
	—	10.58	-8.02	—
	—	1.82	-0.37	—
	—	0.04	0.03	—
	—	4.56	3.15	—
	—	117.2	151.0	—
Balance sheet
	—	166.62	147.95	—
	—	86.95	68.27	—
	—	0.20	0.24	—
	—	19.86	27.63	—
	—	44.94	34.04	—
	—	9.59	5.28	—
	—	69.64	73.13	—
	—	19.67	11.70	—
	—	34.02	21.20	—
	—	4.76	3.39	—
	—	3.73	1.33	—
	—	1.03	2.06	—
	—	122.48	115.19	—
Cash flow
	—	14.29	-4.08	—
	—	-14.69	19.75	—
	—	0.35	-15.84	—
	—	3.71	3.94	—

Metric	Q2 FY27	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24
Income statement
	13.92	10.19	11.28	12.71	12.64	13.73	9.70	9.45	11.50	12.29	—
	0.53	0.07	0.03	0.00	0.53	0.04	0.03	0.57	10.19	0.14	—
	14.45	10.26	11.30	12.71	13.17	13.77	9.73	10.02	21.69	12.43	—
	13.57	11.52	12.46	12.85	13.58	14.07	11.70	10.87	12.71	13.66	—
	1.03	1.42	1.00	1.24	1.61	1.61	1.32	0.66	1.47	1.36	—
	5.10	5.47	5.72	4.01	5.45	7.03	3.75	3.57	3.41	3.87	—
	2.42	2.46	2.27	2.40	2.64	2.37	2.20	2.00	2.43	2.41	—
	0.14	0.14	0.12	0.15	0.15	0.10	0.09	0.13	0.33	0.39	—
	0.70	0.69	0.69	0.71	0.71	0.70	0.69	0.73	0.71	0.71	—
	4.19	3.75	3.38	3.18	3.63	3.72	3.24	2.89	3.26	3.38	—
	0.88	-1.26	-1.16	-0.14	-0.41	-0.30	-1.97	-0.85	8.98	-1.24	—
	0.00	0.00	0.00	0.00	0.00	0.00	0.00	—	—	—	—
	0.88	-1.26	-1.16	-0.14	-0.41	-0.30	-1.97	-0.85	8.98	-1.24	—
	0.23	-0.18	0.20	0.03	-0.10	0.03	-0.57	0.08	0.95	0.02	—
	0.66	-1.07	-0.96	-0.17	-0.31	-0.27	-1.40	-0.77	8.03	-1.22	—
	1.11	-1.82	-1.63	-0.29	-0.53	-0.46	-2.38	-1.31	13.62	-2.07	—
Key metrics
	1.72	-0.43	-0.35	0.72	0.45	0.50	-1.19	0.01	10.02	-0.14	—
	12.40%	-4.20%	-3.10%	5.70%	3.60%	3.60%	-12.30%	0.10%	87.10%	-1.10%	—
	4.70%	-10.50%	-8.50%	-1.30%	-2.50%	-2.00%	-14.40%	-8.10%	69.80%	-9.90%	—
	1.80%	—	-1.90%	—	-0.50%	—	-3.20%	—	—	—	—
	10.10%	-25.80%	16.30%	34.50%	9.90%	11.70%	—	—	—	—	—
	312.90%	-296.30%	31.40%	77.90%	-103.90%	77.90%	—	—	—	—	—

Metric	TTM	FY26	FY25	FY24
Income statement
	48.10	50.35	42.95	—
	0.63	0.59	10.92	—
	48.72	50.94	53.87	—
	50.40	52.95	48.94	—
	4.69	5.46	4.82	—
	20.30	22.20	14.60	—
	9.55	9.69	9.05	—
	0.55	0.53	0.94	—
	2.79	2.80	2.85	—
	14.50	13.91	12.76	—
	-1.68	-2.01	4.93	—
	0.00	0.00	0.00	—
	-1.68	-2.01	4.93	—
	0.28	-0.29	0.29	—
	-1.54	-1.72	4.64	—
	-2.63	-2.91	7.87	—
Key metrics
	1.66	1.32	8.72	—
	3.45%	2.60%	20.30%	—
	-3.20%	-3.40%	10.80%	—
	—	-2.70%	10.10%	—
	5.67%	17.20%	—	—
	—	-137.10%	—	—
	—	-2.33	-4.01	—
	—	1.17	-0.34	—
	—	0.05	0.01	—
	—	2.68	0.28	—
	—	65.6	57.9	—
Balance sheet
	—	73.54	71.40	—
	—	20.03	16.06	—
	—	0.02	0.02	—
	—	5.97	5.26	—
	—	10.64	7.81	—
	—	3.05	2.30	—
	—	26.90	29.34	—
	—	7.56	6.26	—
	—	17.76	13.47	—
	—	2.70	0.30	—
	—	2.70	0.30	—
	—	0.00	0.00	—
	—	54.43	56.08	—
Cash flow
	—	-2.02	-1.59	—
	—	0.28	16.14	—
	—	1.75	-14.56	—
	—	0.31	2.42	—

Compounded growth

Standalone

Sales CAGR 3Y: —
Sales CAGR 5Y: —
Profit CAGR 3Y: —
Profit CAGR 5Y: —
Sales YoY (TTM): +5.67%
Profit YoY (TTM): +44.00%

Consolidated

Sales CAGR 3Y: —
Sales CAGR 5Y: —
Profit CAGR 3Y: —
Profit CAGR 5Y: —
Sales YoY (TTM): +24.20%
Profit YoY (TTM): +387.40%

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Sep 2026

Promoter holding: 61.26%

Quarter	30 Sep 2026	September 2026	June 2026
Promoter %	61.26%	61.26%	61.26%

Holder	Type	Holding	Previous	Change
KAYGEE INVESTMENTS PRIVATE LIMITED	Promoter Group	36.88%	36.88%	0.00%
KAYGEE LABORATORIES PRIVATE LIMITED	Promoter Group	14.35%	14.35%	0.00%
INVESTOR EDUCATION AND PROTECTION FUND AUTHORITY MINISTRY OF CORPORATE AFFAIRS	Public	2.83%	2.83%	0.00%
TANVI JIGNESH MEHTA	Public	2.41%	2.41%	0.00%
PREMCHAND GODHA	Promoter	2.15%	2.15%	0.00%
PRASHANT GODHA	Promoter	2.08%	2.08%	0.00%
NIRMAL JAIN	Promoter	1.62%	1.62%	0.00%
CHANDURKAR INVESTMENTS PRIVATE LIMITED	Promoter Group	1.43%	1.43%	0.00%
KETAN DAMODHAR BAHETI	Public	1.21%	1.21%	0.00%
USHA GODHA	Promoter	0.97%	0.97%	0.00%
BHAWNA GODHA	Promoter	0.72%	0.72%	0.00%
USHA M CHANDURKAR	Promoter	0.69%	0.69%	0.00%
SAMEER M CHANDURKAR	Promoter	0.37%	0.37%	0.00%

Public shareholders are disclosed individually only above 1%.

Peer comparison

Company	Mkt cap (₹ Cr)	Price (₹)	P/E	ROCE	Sales YoY	Profit YoY	1Y return
Sun Pharmaceutical Industries Ltd.	4,26,112	1,776.00	38.78	17.90%	+12.13% TTM	+4.79% TTM	+4.92%
Divi's Laboratories Ltd.	2,66,424	10,036.00	91.09	19.00%	+16.35% TTM	+26.84% TTM	+47.61%
Torrent Pharmaceuticals Ltd.	1,79,908	4,730.00	85.71	9.10%	+42.06% TTM	-1.92% TTM	+32.24%
Laurus Labs Limited	1,24,601	2,306.10	93.53	19.70%	+23.03% TTM	+95.38% TTM	+134.59%
Zydus Lifesciences Limited	1,18,703	1,190.00	25.85	19.20%	+21.11% TTM	-2.51% TTM	+22.32%
Dr. Reddy's Laboratories Ltd.	1,14,513	1,372.00	41.50	13.90%	-3.53% TTM	-51.90% TTM	+14.26%
Cipla Ltd.	1,13,110	1,400.10	39.63	14.90%	-0.74% TTM	-47.48% TTM	-6.88%
Mankind Pharma Limited	1,04,631	2,533.15	46.22	13.70%	+13.27% TTM	+27.60% TTM	+6.91%
Aurobindo Pharma Ltd.	97,878	1,701.10	26.38	13.60%	+9.09% TTM	+9.48% TTM	+47.79%
Lupin Ltd	92,145	2,015.00	17.65	28.40%	+24.22% TTM	+20.10% TTM	+0.84%
Glenmark Pharmaceuticals ltd	70,608	2,501.85	39.27	16.20%	+32.94% TTM	+138.48% TTM	+35.48%
Alkem Laboratories Limited	62,054	5,190.00	28.15	18.80%	+13.36% TTM	-5.52% TTM	-8.38%
Abbott India Ltd. S	57,685	27,146.85	35.73	41.90%	+6.29% TTM	+11.18% TTM	-7.56%
Biocon Ltd.	56,061	344.00	134.63	2.90%	+5.70% TTM	-55.37% TTM	-9.53%
Gland Pharma Limited	52,105	3,157.70	46.16	13.70%	+17.57% TTM	+46.55% TTM	+65.09%
Ipca Laboratories Ltd.	50,051	1,973.15	36.40	16.40%	+10.59% TTM	+67.91% TTM	+52.33%
GlaxoSmithkline Pharmaceuticals Ltd.	42,904	2,532.60	37.42	55.40%	+12.12% TTM	+20.03% TTM	-4.84%
Ajanta Pharma Ltd.	41,406	3,313.55	32.79	29.40%	+25.01% TTM	+29.70% TTM	+26.89%
Emcure Pharmaceuticals Limited	41,254	2,174.55	37.75	25.10%	+21.12% TTM	+33.34% TTM	+64.07%
J.B. Chemicals & Pharmaceuticals Lt	38,731	2,412.25	47.77	21.90%	+5.87% TTM	+7.56% TTM	+45.79%
Sai Life Sciences Limited	32,855	1,546.30	90.80	18.10%	—	—	+67.49%
PIRAMAL PHARMA LIMITED	31,659	237.80	-151.21	0.80%	+9.43% TTM	-781.93% TTM	+18.60%
ACUTAAS CHEMICALS LIMITED	30,928	3,777.65	70.51	27.70%	+45.18% TTM	+95.78% TTM	+106.30%
Wockhardt Ltd	30,869	1,899.80	76.22	6.40%	+25.70% TTM	+894.12% TTM	+39.18%
RUBICON RESEARCH LIMITED	28,416	1,716.55	98.59	24.30%	—	—	+164.06%
Makers Laboratories Ltd.	127	215.10	6.70	9.00%	+24.20% TTM	+387.40% TTM	+72.84%

Filings & corporate actions

Recent announcements

Standalone and Consolidated Financial Results for second quarter and half year ended 30.09.20264 Nov 2026 · Result / Financial Results
Standalone and Consolidated Financial Results for second quarter and half year ended 30.09.20264 Nov 2026 · Board Meeting / Outcome of Board Meeting
Makers Laboratories Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/11/2026 ,inter alia, to consider and approve Standalone and Consolidated ....21 Oct 2026 · Board Meeting / Board Meeting
Postal Ballot - Outcome of Postal Ballot19 Oct 2026 · AGM/EGM / Postal Ballot
Postal Ballot - Voting Results and Scrutinizer Report19 Oct 2026 · AGM/EGM / Postal Ballot
Certificate under Reg 74(5)12 Oct 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Closure of Trading Window22 Sep 2026 · Insider Trading / SAST / Closure of Trading Window
Newspaper Publication17 Sep 2026 · Company Update / Newspaper Publication
Appointment of Mr. Saahil Parikh as Non-Executive, Non-Independent Director of the Company liable to retire by rotation.10 Sep 2026 · AGM/EGM / Postal Ballot
Credit Rating for Bank Facilities1 Sep 2026 · Company Update / Credit Rating
Copy of Newspaper Publication10 Aug 2026 · Company Update / Newspaper Publication
Voting Results and Scrutinizer Report7 Aug 2026 · AGM/EGM / AGM
41st Annual General Meeting of the Company7 Aug 2026 · AGM/EGM / AGM
Change in Directorship of Mr. Saahil Parikh from Wholetime Director to Non-Executive, Non-Independent Wholetime Director7 Aug 2026 · Company Update / Change in Management
Standalone and Consolidated Financial Results for Q1FY277 Aug 2026 · Result / Financial Results
Outcome of Board Meeting7 Aug 2026 · Board Meeting / Outcome of Board Meeting
Makers Laboratories Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2026 ,inter alia, to consider and approve Standalone and Consolidated ....23 Jul 2026 · Board Meeting / Board Meeting
Intimation to shareholders regarding weblink of Annual Report13 Jul 2026 · Company Update / General
Copy of Newspaper Publication13 Jul 2026 · Company Update / Newspaper Publication
Certificate under Regulation 74(5)10 Jul 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
41st Annual General Meeting of the Company to be held on Friday, 7th August, 2026 at 12.30 p.m. through Video Conference10 Jul 2026 · AGM/EGM / AGM
Annual Report 2025-2610 Jul 2026 · Others / Reg. 34 (1) Annual Report
Copy of Newspaper Publication2 Jul 2026 · Company Update / Newspaper Publication
Closure of Trading Window23 Jun 2026 · Insider Trading / SAST / Closure of Trading Window
Enclosed copy of newspapers9 Jun 2026 · Company Update / Newspaper Publication
Copy of Newspaper Publication27 May 2026 · Company Update / Newspaper Publication
Annual Secretarial Compliance Report for the period ended 31st March, 2026.27 May 2026 · Company Update / Reg.24(A)-Annual Secretarial Compliance
Standalone and Consolidated Results for FY 25-2626 May 2026 · Result / Financial Results
Standalone and Consolidated Financial Results for FY 25-2626 May 2026 · Board Meeting / Outcome of Board Meeting
Makers Laboratories Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/05/2026 ,inter alia, to consider and approve Standalone and Consolidated ....5 May 2026 · Board Meeting / Board Meeting
Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended March 31, 2026.6 Apr 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Closure of Trading Window16 Mar 2026 · Insider Trading / SAST / Closure of Trading Window
Copy of Newspaper Publication11 Feb 2026 · Company Update / Newspaper Publication
Standalone and Consolidated Financial Results for 3rd quarter and nine months ended 31.12.202510 Feb 2026 · Result / Financial Results
Standalone and Consolidated Financial Results for 3rd quarter and nine months ended 31.12.202510 Feb 2026 · Board Meeting / Outcome of Board Meeting
Re-lodgement of transfer requests report - November 2025 and December 202521 Jan 2026 · Company Update / General
Makers Laboratories Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2026 ,inter alia, to consider and approve Standalone and Consolidated ....21 Jan 2026 · Board Meeting / Board Meeting
The Company has enclosed herewith RTA certficate under Reg 74 (5) of SEBI DP Regulations 2018 for the quarter ended 31.12.2025.8 Jan 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Closure of Trading Window22 Dec 2025 · Insider Trading / SAST / Closure of Trading Window
Re-lodgement of transfer requests of physical shares report - October 202518 Nov 2025 · Company Update / General

Board meetings

4 Nov 2026 Board Meeting - Financial Results
7 Aug 2026 Board Meeting - Financial Results